Randomized double-blind placebo-controlled trial of vorapaxar for HIV-associated inflammation and coagulopathy - the ADVICE study

被引：0
|
作者：
Kent, S. [1 ]
机构：
[1] Univ Melbourne, Peter Doherty Inst, Dept Microbiol & Immunol, Melbourne, Vic, Australia
来源：
ANTIVIRAL THERAPY | 2018年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
O13
引用
收藏
页码：A15 / A15
页数：1
相关论文
共 50 条
  • [1] Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial
    Kent, Stephen J.
    Hough, Sally
    Law, Matthew G.
    Hutchinson, Jolie
    van Bockel, David
    Kelleher, Anthony D.
    Catalfamo, Marta
    Lane, Cliff
    Baker, Jason V.
    Emery, Sean
    LANCET HIV, 2018, 5 (10): : E553 - E559
  • [2] Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial (vol 5, pg e553, 2018)
    LANCET HIV, 2019, 6 (12): : E815 - E815
  • [3] Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment
    Heseltine, PNR
    Goodkin, K
    Atkinson, JH
    Vitiello, B
    Rochon, J
    Heaton, RK
    Eaton, EM
    Wilkie, FL
    Sobel, E
    Brown, SJ
    Feaster, D
    Schneider, L
    Goldschmidts, WL
    Stover, ES
    ARCHIVES OF NEUROLOGY, 1998, 55 (01) : 41 - 51
  • [4] A randomized, double-blind, placebo-controlled trial of deprenyl and thiotic acid in HIV-associated cognitive impairment
    Roesler, R
    Quevedo, J
    Walz, R
    Bianchin, M
    NEUROLOGY, 1999, 52 (09) : 1920 - 1920
  • [5] Effects of thalidomide on HIV-associated wasting syndrome: A randomized, double-blind, placebo-controlled clinical trial
    ReyesTeran, G
    SierraMadero, JG
    delCerro, VM
    ArroyoFigueroa, H
    Pasquetti, A
    Calva, JJ
    RuizPalacios, GM
    AIDS, 1996, 10 (13) : 1501 - 1507
  • [6] A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in HIV-associated cognitive impairment
    不详
    ANNALS OF NEUROLOGY, 1997, 42 (03) : M130 - M130
  • [7] Oxandrolone in the treatment of HIV-associated weight loss in men - A randomized, double-blind, placebo-controlled study
    Grunfeld, C
    Kotler, DP
    Dobs, A
    Glesby, M
    Bhasin, S
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (03) : 304 - 314
  • [8] Rivastigmine for the Treatment of HIV-Associated Neurocognitive Disorders: A Randomized, Double-Blind, Placebo-Controlled, Crossover Pilot Study
    Simioni, Samanta
    Cavassini, Matthias
    Michel, Melanie
    Annoni, Jean Marie
    Iglesias, Katia
    Abraham, Aline Rimbault
    Calmy, Alexandra
    Giacobini, Ezio
    Hirschel, Bernard
    Du Pasquier, Renaud
    NEUROLOGY, 2012, 78
  • [9] CHOLECALCIFEROL SUPPLEMENTATION AND INFLAMMATION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL
    Seibert, Eric
    Ulrich, Christof
    Trojanowicz, Bogusz
    Lehmann, Ulrike
    Dierkes, Jutta
    Stangl, Gabriele I.
    Girndt, Matthias
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [10] Double-blind randomized placebo-controlled trial of sibutramine
    Bray, GA
    Ryan, DH
    Gordon, D
    Heidingsfelder, S
    Cerise, F
    Wilson, K
    OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
12345